论文部分内容阅读
用西蒙1号治疗原发性及继发性血小板减少性紫癜50例,有效率原发性及继发性血小板减少性紫癜均为70%,经毒理研究及临床观察均无明显毒副作用,本文还对其作用机理进行了初步探讨。
With Simon treatment of 50 cases of primary and secondary thrombocytopenic purpura, the effective rate of primary and secondary thrombocytopenic purpura were 70%, toxicological studies and clinical observations have no significant side effects, In this paper, the mechanism of action is also discussed.